Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Lie Yu
Neoadjuvant disitamab vedotin (RC-48) plus a PD-1 inhibitor in muscle-invasive bladder cancer: a multicenter real-world study with stratification by HER2 expression and tertiary lymphoid structures
Abstract Objective: To assess the efficacy and safety of neoadjuvant RC-48 combined with a PD-1 inhibitor in patients with muscle-invasive bladder cancer (MIBC), and to investigate the stratification utility of HER2 expression and tumor-associated tertiary lymphoid structures (TLS) as predictive variables for treatment response and clinical prognosis.
Hydrodynamic characteristics during floating and installation of high blockage-ratio immersed tunnels in Inland Rivers
Abstract To investigate the hydrodynamic challenges associated with the high blockage-ratios encountered during the floating transportation and installation of immersed tubes in restricted inland waterways, a cross-river immersed tunnel project in Dongguan is selected as a case study.
Efficacy Evaluation of Urethral Dragging-and-Adhesion Anastomosis in Ileal Orthotopic Neobladder Reconstruction Following Laparoscopic Radical Cystectomy: a dual-center retrospective study
ORIGINAL RESEARCH article Volume 13 - 2026 | doi: 10.3389/fsurg.2026.1874547 Reviewed by ORIGINAL RESEARCH article XC Xin Chang Zou 2 HC HAICHAO CHAO 2 TZ Tao Zeng 2 1. Nanchang University, Nanchang, China 2. Second Affiliated Hospital of Nanchang University, Nanchang, China 3.
Disitamab Vedotin (RC48) Combined with PD-1 Inhibitors in Locally Advanced or Metastatic Urothelial Carcinoma: Clinical Outcomes and Prognostic Factors from a Multicenter Real-World Study
ORIGINAL RESEARCH article Volume 17 - 2026 | doi: 10.3389/fimmu.2026.1815591 Reviewed by ORIGINAL RESEARCH article XC Xin Chang Zou 1 TZ Tao Zeng 6 1. Second Affiliated Hospital of Nanchang University, Nanchang, China 2. Jiangxi Provincial People's Hospital, Nanchang, China 3. Jiangxi Cancer Hospital, Nanchang, China 4. The First Affiliated Hospital of Nanchang University, Nanchang, China 5. Affiliated Jiujiang Hospital of Nanchang University, Jiujiang, China 6.
Engineered long-acting Irisin-albumin binding domain fusion protein for enhanced anti-inflammatory efficacy in lipopolysaccharide-induced systemic inflammation | Communications Biology
Abstract Irisin is a peptide hormone with notable anti-inflammatory and metabolic regulatory effects but has limited clinical utility due to its extremely short plasma half-life (< 1 h). In this study, we engineered an albumin-binding domain (ABD)-conjugated Irisin (ABD-Irisin) fusion protein to significantly extend half-life and enhance therapeutic potency.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Lie
Contact Lie, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack